JGRO JPMorgan Active Growth ETF

Expense Ratio
0.44%
Dividend
0.15%
Previous close
$94.89
Est. 12 months change
+21.91%
Projected Price
$115.69

Profitability Metrics

Return on Equity (ROE)
52.74%
Return on Assets (ROA)
16.51%
Return on Invested Capital (ROIC)
38.46%
Weighted Average Cost of Capital (WACC)
11.39%
ROIC - WACC
27.07%
Updated : 2026-08-06 19:54 ET

Valuation Metrics

P/E Ratio
7.88
Forward P/E
24.22
PEG Ratio
1.57
Debt Current Ratio
2.22

Growth & Cash Flow

Gross Margin
58.32%
Operating Margin
29.05%
FCF Margin
25.09%
TTM Revenue Growth
49.21%
Projected 12M EPS Growth
-67.46%

Price Change

Price % from 50 SMA
-0.43%
Price % from 200 SMA
2.44%
6 Months
5.95%
1 Year
6.99%
2 Years
38.00%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
GOOG11.89%
NVDA11.59%
AAPL5.67%
AVGO5.06%
AMD2.91%
MU2.88%
META2.28%
TSLA2.27%
LLY2.08%
PANW1.71%

ETF Analysis

Fund Overview

JPMorgan Active Growth ETF (JGRO) currently reports 127 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is GOOG (11.89%), NVDA (11.59%), AAPL (5.67%), with GOOG as the largest single weight at 11.89%. Together, the top three holdings account for 29.15%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 38.46%, WACC is 11.39%, and the economic spread is 27.07%. On balance, the spread between returns and capital costs is exceptional, meaning reinvested capital is creating significant incremental value at the portfolio level. Supporting metrics show ROE at 52.74% and ROA at 16.51%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Assessed on a multiple basis, trailing P/E of 7.88, forward P/E of 24.22, PEG of 1.57. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio carries an aggregate current ratio of 2.22, consistent with adequate near-term liquidity management. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 58.32%, operating margin at 29.05%, and free cash flow margin at 25.09%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. The portfolio's FCF margin is a standout — reflecting businesses where accounting profits translate cleanly into real cash generation. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 22.13%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 49.21% suggesting the portfolio's businesses are collectively capturing meaningful market share or pricing power. The forward EPS growth estimate of -67.5% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.